Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use

Exclusion Criteria

• •Retinal disease (e.g., wet age-related macular degeneration, proliferative diabetic retinopathy, central retinal vein occlusion)
• •Use of topical or systemic immunosuppressor or immunomodulator drug (e.g., steroids, cyclosporine, lifitegrast, or antihistamines)
• •Use of preservative-free hypotensive medications
• •Any clinical contraindications to receiving intracameral bimatoprost implantation
• •History of recurrent conjunctivitis (e.g., allergic or atopic conjunctivitis)
• •History of partial or full corneal transplant
• •History of ophthalmic surgery (intraocular or tarsus-involving oculoplastic procedures) within last 6 months
• •History of subconjunctival glaucoma surgery (i.e., trabeculectomy, aqueous shunt, Xen implant) within last 6 months